Biocryst Pharmaceuticals buy Royal Bank of Canada
Start price
07.07.26
/
50%
€9.52
Target price
07.07.27
€12.24
Performance (%)
1.24%
Price
07.07.26
€9.64
Summary
This prediction is currently active. With a performance of 1.24%, the BUY prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals is trending in the right direction. This prediction currently runs until 07.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biocryst Pharmaceuticals | 1.24% |
| iShares Core DAX® | 4.367% |
| iShares Nasdaq 100 | -0.294% |
| iShares Nikkei 225® | -0.471% |
| iShares S&P 500 | 1.267% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (BCRX) had its price target raised by Royal Bank Of Canada from $13.00 to $14.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.59
30.01.26
30.01.26
€10.92
30.01.27
30.01.27
72.57%
07.07.26
07.07.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.60
30.06.25
30.06.25
€11.09
30.06.26
30.06.26
14.00%
01.07.26
01.07.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€8.90
06.05.25
06.05.25
€11.51
06.05.26
06.05.26
-16.23%
07.05.26
07.05.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.91
11.04.25
11.04.25
€9.75
11.04.26
11.04.26
39.83%
12.04.26
12.04.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.79
25.02.25
25.02.25
€10.47
25.02.26
25.02.26
-19.06%
26.02.26
26.02.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.61
05.11.24
05.11.24
€9.16
05.11.25
05.11.25
-6.99%
06.11.25
06.11.25
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.95
25.09.23
25.09.23
€9.44
25.09.24
25.09.24
-2.42%
26.09.24
26.09.24